Division of Allergy Pulmonary and Critical Care Medicine Archive — Page 8 of 13

Pierre Massion, MD, wearing glasses, a dark sweater, and collared shirt outdoors.
April 6, 2021

Vanderbilt mourns the passing of Pierre Massion

Pierre Massion, MD, Cornelius Vanderbilt Chair and Professor of Medicine, an internationally known expert on early detection and prevention strategies for lung cancer, died April 4 of an apparent heart attack. He was 58.

By Tom Wilemon
Portrait of a smiling person wearing a white medical coat and striped tie outdoors.
April 1, 2021

Stone lands faculty development award

The American Academy of Allergy, Asthma and Immunology Foundation has awarded a three-year, $240,000 Faculty Development Award to Cosby Stone Jr., MD, MPH, instructor in Medicine at Vanderbilt University Medical Center.

By Paul Govern
Allison Norlander, PhD, R. Stokes Peebles, MD, and colleagues are studying an approved drug that enhances immune cells and might be useful for treating inflammatory and autoimmune diseases.
March 25, 2021

Team studies new use for pulmonary hypertension drug

An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered.

By Leigh MacMillan
Tree-lined courtyard facing a brick-and-stone institutional building with an ornate arched entrance and carved lettering above the doorway.
February 25, 2021

School of Medicine Faculty Advisory Council Re-Established

After a several-year hiatus, the Vanderbilt University School of Medicine Faculty Advisory Council has been re-established to represent the School’s 3,000-plus faculty.

By John Howser
VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
February 11, 2021

Vanderbilt, Zambia researchers find delirium in hospitalized patients linked to mortality, disability in Sub-Saharan Africa

Delirium, a form of acute brain dysfunction, is widespread in critically ill patients in lower resourced hospitals, and the duration of delirium predicted both mortality and disability at six months after discharge, according to a study published in PLOS ONE.

By Holly Fletcher
Close-up of a high-tech laboratory interface displaying the words “COVID-19” and “VIRUS,” with colorful circuit-like lines and data graphics.
February 5, 2021

Convalescent plasma improved survival in COVID-19 patients with blood cancers

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

By Tom Wilemon